{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:46:40Z","timestamp":1762004800504},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jocn-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jocn.2016.02.009","type":"journal-article","created":{"date-parts":[[2016,4,3]],"date-time":"2016-04-03T11:27:28Z","timestamp":1459682848000},"page":"163-164","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Invasive central nervous system aspergillosis in a patient with Crohn\u2019s disease after treatment with infliximab and corticosteroids"],"prefix":"10.1016","volume":"30","author":[{"given":"Emma-Lee","family":"Bourne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Dimou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2016.02.009_b0005","unstructured":"Disseminated pulmonary Aspergillosus [updated October 2014], Electronic Therapeutic Guidelines (eTG) complete. Melbourne, 2002."},{"key":"10.1016\/j.jocn.2016.02.009_b0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1034\/j.1399-3062.1999.010404.x","article-title":"Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century","volume":"1","author":"Walsh","year":"1999","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jocn.2016.02.009_b0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/00023210-200721040-00004","article-title":"Fungal infections of the CNS: treatment strategies for the immunocompromised patient","volume":"21","author":"Black","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jocn.2016.02.009_b0020","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.medmal.2011.09.011","article-title":"Twenty-nine cases of invasive aspergillosis in neutropenic patients","volume":"41","author":"Saghrouni","year":"2011","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.jocn.2016.02.009_b0025","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ejrad.2005.01.001","article-title":"Initial CT manifestations of invasive pulmonary aspergillosis in 45 non-HIV immunocompromised patients: association with patient outcome?","volume":"55","author":"Horger","year":"2005","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jocn.2016.02.009_b0030","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1182\/blood-2003-01-0267","article-title":"Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study","volume":"102","author":"Marty","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jocn.2016.02.009_b0035","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor \u03b1\u2013neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2016.02.009_b0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1128\/IAI.73.1.39-49.2005","article-title":"Transient neutralization of tumor necrosis factor alpha can produce a chronic fungal infection in an immunocompetent host: potential role of immature dendritic cells","volume":"73","author":"Herring","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.jocn.2016.02.009_b0045","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM200104053441415","article-title":"Invasive pulmonary aspergillosis associated with infliximab therapy","volume":"344","author":"Warris","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2016.02.009_b0050","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1053\/j.gastro.2008.01.012","article-title":"Risk factors for opportunistic infections in patients with inflammatory bowel disease","volume":"134","author":"Toruner","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jocn.2016.02.009_b0055","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.clineuro.2009.02.007","article-title":"Preoperative antifungal therapy may improve survival in patients with Aspergillus brain abscess","volume":"111","author":"Wasay","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jocn.2016.02.009_b0060","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1080\/02688690902887549","article-title":"Never go to sleep on undrained pus: a retrospective review of surgery for intraparenchymal cerebral abscess","volume":"23","author":"Smith","year":"2009","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.jocn.2016.02.009_b0065","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","article-title":"Aspergillosis case-fatality rate: systematic review of the literature","volume":"32","author":"Lin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jocn.2016.02.009_b0070","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood-2005-02-0733","article-title":"Improved outcome in central nervous system aspergillosis, using voriconazole treatment","volume":"106","author":"Schwartz","year":"2005","journal-title":"Blood"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586816000965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586816000965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T14:57:09Z","timestamp":1536850629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586816000965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":14,"alternative-id":["S0967586816000965"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2016.02.009","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invasive central nervous system aspergillosis in a patient with Crohn\u2019s disease after treatment with infliximab and corticosteroids","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2016.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2016 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}